WO2000030998A1 - Porous ceramic composites - Google Patents

Porous ceramic composites Download PDF

Info

Publication number
WO2000030998A1
WO2000030998A1 PCT/US1999/027378 US9927378W WO0030998A1 WO 2000030998 A1 WO2000030998 A1 WO 2000030998A1 US 9927378 W US9927378 W US 9927378W WO 0030998 A1 WO0030998 A1 WO 0030998A1
Authority
WO
WIPO (PCT)
Prior art keywords
porous ceramic
average
fibers
ceramic
volume
Prior art date
Application number
PCT/US1999/027378
Other languages
French (fr)
Inventor
Melissa Crimp
Michelle Hignite
Ping Zhang
Loic M. Dejardin
Original Assignee
Board Of Trustees Operating Michigan State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Board Of Trustees Operating Michigan State University filed Critical Board Of Trustees Operating Michigan State University
Priority to AU19162/00A priority Critical patent/AU1916200A/en
Publication of WO2000030998A1 publication Critical patent/WO2000030998A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/12Phosphorus-containing materials, e.g. apatite
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B38/00Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof
    • C04B38/0051Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof characterised by the pore size, pore shape or kind of porosity
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2111/00Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
    • C04B2111/00474Uses not provided for elsewhere in C04B2111/00
    • C04B2111/00836Uses not provided for elsewhere in C04B2111/00 for medical or dental applications

Definitions

  • the present invention relates generally to ceramic compositions and, more particularly, to highly porous ceramics made from such compositions which have improved compressive strength and toughness.
  • the invention also relates to the methods of manufacturing the highly porous ceramics of the present invention.
  • porous ceramics Due to their chemical inertness and stability at high temperatures, the desire for porous ceramics has increased dramatically in recent years. A relatively recent trend in the porous ceramic art has been its attempted use in bone substitution processes. The porous ceramics used in bone
  • HA hydroxyapatite
  • Hydroxyapatite is known to have superior biocompatibility, that is, it is
  • micropores in the macropore structure wall. This may promote cellular adhesion and differentiation. Interconnected micropores are also important in allowing the flow of body fluid (nutritional supply) between the
  • macropores to promote the growth of the bone in the macropores of an implant.
  • porous ceramics are considered to be useful for bone substitution applications, a perceived problem with using porous
  • HA hydroxyapatite
  • the present invention relates in part to structurally reinforced porous HA ceramic compositions. Reinforcing porous HA ceramics with short and/or continuous fibers will increase the strength and toughness, to
  • tricalcium phosphate TCP sintered form of HA
  • biocompatible reinforcements and/or fiber migration To minimize the potential for reaction, it is necessary to choose a material with superior biocompatibility and the ability to chemically bond to the matrix.
  • porous ceramics have included impregnating polymeric sponges having interconnected macropores with a ceramic slurry
  • the polymeric sponge method is work intensive and requires binders, to provide adequate
  • Binders such as aluminum orthophosphate, sodium silicate or magnesium orthoborate can leave behind residual phosphates which are susceptible to chemical attack. Residual binders, as well as anti-foaming agents and rheological agents which are useful for improving wetability, can
  • Another known method involving the process of forming HA ceramics includes manufacturing porous HA sheets by a tape casting technique with a gas forming agent such as CaCO 3 . While the resulting ceramic had a relatively high porosity, i.e., up to about 62%, the pore diameter was limited
  • porous HA ceramics Another known process of producing porous HA ceramics is via a lost wax process which uses a negative wax replica of a porous skeletal microstructure, filled with a ceramic slurry. The wax burns off during firing,
  • pores of the skeleton and for the case of in vivo use are biocompatible. Uniformity in the distribution of reinforcing fibers is also considered to pose
  • the present invention is thus directed to porous ceramic composites
  • porous ceramics composites of the present invention are generally made according to the following method in which an electrolyte solution such as 10 '3 M KNO 3 electrolyte including approximately 30% by volume of concentrated H 2 O 2 is originally provided. Added to this electrolyte solution, preferably with constant mixing is a particulate material selected from the group consisting essentially
  • reinforcing fibers selected from the group consisting essentially
  • AI 2 O 3 and hydroxyapatite fibers are optionally added to the composition in an amount of up to about 8.0 percent by volume of the solid portion of the composite.
  • the fibers, whether short or continuous, are added directly to the composite under constant mixing at ambient temperatures until
  • a creamy suspension (slurry) is obtained.
  • the creamy suspension is then introduced into molds having the desired shape and covered with a porous foil which serves to assist in regulating the pore size and uniformity of pore distribution while simultaneously allowing the evolving gas to escape.
  • the composition is then placed in a drying furnace to obtain the porous "green structure". With heating, the hydrogen peroxide breaks down into water and free oxygen. The free oxygen bubbles up through the sample creating the interconnected porous structure in its wake.
  • the dried samples are cooled in air at room
  • the resulting porous ceramic can be milled to form granules of a desired size and shape, thus allowing the granules to be used for a variety of applications.
  • macropores of between 200 and 400 ⁇ m are generally considered to be necessary to allow
  • the fiber reinforced porous HA Since ceramics having an open porosity in the above mentioned range are thought to have a structure closely related to cancellous bone which is subsequently converted to cortical bone through a progressive deposition of new bone lamellae by a series of osteons, the fiber reinforced porous HA
  • ceramics of the present invention are believed to be ideal candidates for biocompatible implants.
  • Micropores in the macropore structure wall increases the adsorption areas and may provide a favorable surface for cellular adhesion and
  • Interconnected micropores are also important in allowing the flow of body fluid (nutritional supply) between the macropores to promote the growth of the bone in the macropores.
  • Microstructural evaluation of these composites shows interconnected microporosity.
  • Figure 1a is a stereomicrograph showing the microstructure of an
  • Figure 1 b is a stereomicrograph showing the microstructure of an AI 2 O 3(f) /HA composite
  • Figure 1c is a stereomicrograph showing the microstructure of an
  • Figure 2 is a stereomicrograph of a AI 2 O 3(f) /HA composite depicting the microporous structure
  • Figure 3 is a graph plotting pore diameter as a function of HA powder volume percent
  • Figure 4 is a graph plotting pore diameter as a function of fiber volume percent
  • Figure 5 is a graph plotting percent porosity as a function of fiber volume percent
  • Figure 6 is a graph plotting pore diameter as a function of H 2 O 2 content in AI 2 O 3(f) /HA composites.
  • Figure 7 is an energy spectrum of an AI 2 O 3(f) /HA composite from energy dispersive spectroscopy.
  • One aspect of the present invention generally relates to a method for fabricating a porous ceramic composite.
  • the method includes as a first step
  • the electrolyte solution is generally selected from the group consisting essentially of NaCI,
  • the electrolyte concentrations range from 10 '7 M to 4.0 M, depending on
  • an electrolyte such as 10 "3 M KNO 3 including a 30% concentration of H 2 O 2 is useful for ceramic composites comprised of hydroxyapatite particles and hydroxyapatite fibers.
  • 0.154 M NaCI is useful for interactions between titanium and hydroxyapatite.
  • the next step of the method involves adding between about 20.0 volume percent to about 35.0 volume percent of a relatively fine particulate material b) selected from the group consisting essentially of alumina powder, hydroxyapatite powder or mixtures thereof to the solution a) while stirring the same.
  • alumina powder will have an average particle size of between about 50 nanometers (nm) to about 100 micrometers ⁇ m), with a range of 0.2 ⁇ m to 0.6 ⁇ m being preferred.
  • Alumina powders (AI 2 O 3 ) such as those marketed by Sumitomo Chemical Co. Ltd. under the trade designation AKP-30 and AKP-50 have been found to be particularly useful.
  • the hydroxyapatite powders preferably will have an average particle size of between about 0.1 ⁇ m to about 100 ⁇ m, with a range of 6 ⁇ m to about 14 ⁇ m being preferred. Hydroxyapatite particles such as those offered commercially by Hitemco iv idical Appliances, Inc. have been found to be particularly useful.
  • a fiber component c) may be added to the solution before sintering. While any suitable biocompatible fiber may be employed, fibers selected from the group consisting essentially of alumina fibers, hydroxyapatite fibers or mixtures thereof are preferred. The total amount of
  • the fibers added will be an amount sufficient to form a relatively pasty slurry. In this regard, it has been found up to about 8.0% by volume of the solid portion of the fibers are suitable, with a range of 4.0% volume to 5.0% by volume being preferred.
  • the alumina fibers if employed, may be continuous or may be chopped to an average length of less than about 10 mm. More preferably, the short alumina fibers will have an average length of between about 0.5 mm to about 7.0 mm, with a range of between about 1.0 mm to about 3.0 mm being most preferred.
  • the alumina fibers will also preferably have an average diameter of less than 1.0 mm.
  • the alumina fibers will have an average diameter of between about 5.0 ⁇ m to about 300 ⁇ m with a range of between about 10 ⁇ m to about 14 ⁇ m being most preferred.
  • Such fibers are available from the 3M Corporation under the trade designation NEXTEL AI 2 O 3 fibers.
  • the hydroxyapatite fibers may be in the form of the continuous fibers or may be chopped such that they will have an average length of less than 10 mm. More preferably, the short hydroxyapatite fibers will have an average length of between about 0.5 mm to about 7.0 mm, with
  • the hydroxyapatite fibers will also have an average diameter of less than 1.0
  • the hydroxyapatite fibers will have an average diameter of between about 5.0 ⁇ m to about 300 ⁇ m, with a range of 150 ⁇ m
  • the hydroxyapatite fibers can be made by a simple extrusion method
  • the method includes first, dissolving polyethylene glycol (PEG) in 200 proof ethanol while heating. Hydroxyapatite powder is added at a ratio of 1 part PEG to 3 parts hydroxyapatite powder
  • the slurry is stirred until enough ethanol has evaporated off to provide the desired viscosity.
  • the mixture is then placed into a 3 cc syringe fitted with a 25 gage needle to extrude the fibers out.
  • the fibers are dried at room temperature in air for 24 hours followed by sintering in air at 1350° C for two hours.
  • the foil allows evolving gases to escape while acting to maintain a constant slurry volume and controlling the pore size and uniformity of pore distribution. Absent the foil, the slurry tends to foam out and retract, resulting in a non-uniform ceramic product having uncontrolled pore size and an uneven pore distribution.
  • the composition is placed in a drying furnace to drive off moisture, thus forming a ceramic shell.
  • the shell
  • cooling times and time and temperatures required for sintering the ceramics is material, shape and volume dependent.
  • porous ceramic particularly the non-fiber reinforced porous ceramics, can be any porous ceramic, particularly the non-fiber reinforced porous ceramics.
  • the granules can be used for a number of different applications including but not limited to bone fillers, i.e. filling holes left by bone cysts, bone screws, etc.
  • bone fillers i.e. filling holes left by bone cysts, bone screws, etc.
  • the granules have an average size of between about 1.0 mm to about 2.0 mm.
  • porous compositions employing alumina particulate and/or alumina fibers can be employed to form molten metal filters, fuel sessions and catalyst supports by way of non-limiting example.
  • ceramic compositions employing alumina particulate and alumina fibers may be used for bone
  • slurry samples were prepared as shown in Table 1 below and were placed into cylindrical shaped castings having a depth of 2.5 cm and a diameter of 2.5 cm. The samples were dried for 3.0 hours at 120° C in air and thereafter allowed to cool to room
  • AI 2 O 3(f) /AI 2 O 3 compositions and for 2.0 hours at 1375° C for AI 2 O 3(f) /HA and HA (f) /HA compositions, wherein (f) is indicative of a fiber component.
  • Table 1 is a listing of "typical" values of reactant components and their corresponding results (i e , micro/macro-porosity, density, etc).

Abstract

The present invention relates to ceramic compositions and to the highly porous ceramic formed from such compositions. The highly porous ceramics may be milled to form granules of a particular size and shape, thus making them useful for various applications, particularly biomedical applications. Optionally, the highly porous ceramics may be fiber reinforced such that they have significantly improved compressive strengths and toughness over other ceramic compositions, particularly those used for biomedical applications.

Description

POROUS CERAMIC COMPOSITES
BACKGROUND OF THE INVENTION
The present invention relates generally to ceramic compositions and, more particularly, to highly porous ceramics made from such compositions which have improved compressive strength and toughness. The invention also relates to the methods of manufacturing the highly porous ceramics of the present invention.
DESCRIPTION OF THE ART
Due to their chemical inertness and stability at high temperatures, the desire for porous ceramics has increased dramatically in recent years. A relatively recent trend in the porous ceramic art has been its attempted use in bone substitution processes. The porous ceramics used in bone
substitution often are made of a calcium phosphate composition of the formula [Ca10(PO4)6(OH)2] with a Ca:P ratio of approximately 1 :0.6. This composition is generally referred to as hydroxyapatite (HA).
Hydroxyapatite is known to have superior biocompatibility, that is, it is
known to be chemically similar to human bone and is considered to be an active promoter of bony in-growth, i.e., bio-active. To be useful in bone
substitution applications, it is important for the organic matrix adjacent to the implant to receive calcium and phosphorous which are necessary for
mineralization. These are supplied through the infiltration of a vascular network. Thus, macropores of between 200 and 400 μm are generally considered to be necessary to allow filtration of cellular and vascular
components of bone and blood vessels. Since ceramics having an open porosity in the above mentioned range are thought to have a structure closely related to cancellous bone which is subsequently converted to cortical bone through a progressive deposition of new bone lamellae by a series of osteons, a suitable porous ceramic implant will create the conditions necessary for this deposition. While micropores in the range of 40 - 100 μm
have been shown to allow the in-growth of unmineralized osteoid tissue and pores of 15 - 40 μm permit fibrous tissue penetration, to provide the development of osteons the pore size must generally be at least 200 μm but not larger than 400 μm.
In view of the foregoing, it is desirable to increase the adsorption area by providing micropores in the macropore structure wall. This may promote cellular adhesion and differentiation. Interconnected micropores are also important in allowing the flow of body fluid (nutritional supply) between the
macropores to promote the growth of the bone in the macropores of an implant.
While porous ceramics are considered to be useful for bone substitution applications, a perceived problem with using porous
hydroxyapatite (HA) ceramics for bone substitutes is their lack of strength and
toughness, which necessarily limits their usage to non-load bearing areas.
Accordingly, the present invention relates in part to structurally reinforced porous HA ceramic compositions. Reinforcing porous HA ceramics with short and/or continuous fibers will increase the strength and toughness, to
approach values needed for load-bearing human bone applications.
A potential problem with using fibers, however, is the chance for resorption of the matrix and subsequent release of the fibers into the surrounding tissues. This is particularly true since HA (especially the partially
sintered form of HA called tricalcium phosphate TCP) is thought to partially resorb in a physiological environment over time and porous HA provides
increased surface area as compared to other dense ceramics. With the release of fibers, localized tissue inflammation may result with non-
biocompatible reinforcements and/or fiber migration. To minimize the potential for reaction, it is necessary to choose a material with superior biocompatibility and the ability to chemically bond to the matrix.
Another perceived problem with utilizing porous HA ceramics and particularly short or continuous fiber reinforced HA ceramics is the lack of
quality processing methods offered in the art. For example, previous
methods for fabricating porous ceramics have included impregnating polymeric sponges having interconnected macropores with a ceramic slurry
to obtain a structure replicating that of the sponge. The polymeric sponge method, however, is work intensive and requires binders, to provide adequate
green strength and to prevent collapse of the sponge during the gas evolution
stage, along with anti-foaming and rheological agents. Binders, such as aluminum orthophosphate, sodium silicate or magnesium orthoborate can leave behind residual phosphates which are susceptible to chemical attack. Residual binders, as well as anti-foaming agents and rheological agents which are useful for improving wetability, can
elicit tissue reactions, cause localized inflammation, pain and may lead to rejection of the implant by the body.
Another known method involving the process of forming HA ceramics includes manufacturing porous HA sheets by a tape casting technique with a gas forming agent such as CaCO3. While the resulting ceramic had a relatively high porosity, i.e., up to about 62%, the pore diameter was limited
to only a few microns.
Another known process of producing porous HA ceramics is via a lost wax process which uses a negative wax replica of a porous skeletal microstructure, filled with a ceramic slurry. The wax burns off during firing,
leaving behind macropores. Although successful in terms of producing pores of a known dimension, this process is time and equipment intensive, requiring
specialty manufacturing equipment. Reinforcing additives, which are often required, are limited to materials which can be easily impregnated into the
pores of the skeleton and for the case of in vivo use, are biocompatible. Uniformity in the distribution of reinforcing fibers is also considered to pose
a potential problem.
One other known method of fabricating porous HA ceramics involves
the mixing of ceramic powders with a polymeric powder followed by uniaxail die-pressing. The polymeric particles are removed by heating which initially leaves pores of identical size and shape of the particles. However, the pores tend to become distorted as a result of the die pressing. Again, this method is considered to be unnecessarily labor intensive and the subsequent binder
burn-off process leaves a carbon residue contaminant.
In view of the foregoing, there is a need for a readily repeatable processing method for fabricating highly porous ceramics of controlled pore size which offers improved compressive strength and toughness. Further,
there is a definite need for highly porous ceramics which are biocompatible.
SUMMARY OF THE INVENTION
The present invention is thus directed to porous ceramic composites
and to methods for fabricating porous ceramic composites. The porous ceramics composites of the present invention are generally made according to the following method in which an electrolyte solution such as 10'3M KNO3 electrolyte including approximately 30% by volume of concentrated H2O2 is originally provided. Added to this electrolyte solution, preferably with constant mixing is a particulate material selected from the group consisting essentially
of relatively fine alumina powder having an average particle size of between
about 0.2 μm to about 0.6 μm, hydroxyapatite powder having an average particle size of between about 6.0 μm to about 14.0 μm and mixtures thereof. Thereafter, reinforcing fibers selected from the group consisting essentially
of AI2O3 and hydroxyapatite fibers are optionally added to the composition in an amount of up to about 8.0 percent by volume of the solid portion of the composite. Generally, the fibers, whether short or continuous, are added directly to the composite under constant mixing at ambient temperatures until
a creamy suspension (slurry) is obtained. The creamy suspension is then introduced into molds having the desired shape and covered with a porous foil which serves to assist in regulating the pore size and uniformity of pore distribution while simultaneously allowing the evolving gas to escape. The composition is then placed in a drying furnace to obtain the porous "green structure". With heating, the hydrogen peroxide breaks down into water and free oxygen. The free oxygen bubbles up through the sample creating the interconnected porous structure in its wake. The dried samples are cooled in air at room
temperature and the samples are sintered to obtain a hardened structure. Optionally, the resulting porous ceramic can be milled to form granules of a desired size and shape, thus allowing the granules to be used for a variety of applications.
As alluded to above, in order to be useful in bone substitution applications, proper blood conveyance throughout the ceramic is of major
importance as the blood supplies the calcium and phosphorous needed for the mineralization of the organic matrix as well as providing the humoral
substrate which enables the internal tissue to grow. Thus, macropores of between 200 and 400 μm are generally considered to be necessary to allow
filtration of cellular and vascular components of bone and blood vessels. By controlling processing parameters such as the starting powder and fiber amounts if employed, pores having diameters in this range can be obtained.
Since ceramics having an open porosity in the above mentioned range are thought to have a structure closely related to cancellous bone which is subsequently converted to cortical bone through a progressive deposition of new bone lamellae by a series of osteons, the fiber reinforced porous HA
ceramics of the present invention are believed to be ideal candidates for biocompatible implants.
Micropores in the macropore structure wall increases the adsorption areas and may provide a favorable surface for cellular adhesion and
differentiation. Interconnected micropores are also important in allowing the flow of body fluid (nutritional supply) between the macropores to promote the growth of the bone in the macropores. Microstructural evaluation of these composites shows interconnected microporosity.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1a is a stereomicrograph showing the microstructure of an
AI2O3(f)/AI2O3 composite;
Figure 1 b is a stereomicrograph showing the microstructure of an AI2O3(f)/HA composite;
Figure 1c is a stereomicrograph showing the microstructure of an
HA(f)/HA composite; Figure 2 is a stereomicrograph of a AI2O3(f)/HA composite depicting the microporous structure;
Figure 3 is a graph plotting pore diameter as a function of HA powder volume percent;
Figure 4 is a graph plotting pore diameter as a function of fiber volume percent;
Figure 5 is a graph plotting percent porosity as a function of fiber volume percent;
Figure 6 is a graph plotting pore diameter as a function of H2O2 content in AI2O3(f)/HA composites; and
Figure 7 is an energy spectrum of an AI2O3(f)/HA composite from energy dispersive spectroscopy.
DETAILED DESCRIPTION OF THE INVENTION One aspect of the present invention generally relates to a method for fabricating a porous ceramic composite. The method includes as a first step
providing a) an electrolyte solution having a suitable pH. The electrolyte solution is generally selected from the group consisting essentially of NaCI,
LiCI, CaCI2, NH4CI, MgCI2, BaCI2, Ca(NO3)2, MgSO4, K2SO4, NaNO3, ZnCI2,
K2Cr2O7, Na2PO4, AICI3, KNO3, AI2(SO4)3, KCI, and Ce(NO3)3, by way of non-
limiting example.
The electrolyte concentrations range from 10'7M to 4.0 M, depending
on the particulate and fiber component employed. For instance, an electrolyte such as 10"3M KNO3 including a 30% concentration of H2O2 is useful for ceramic composites comprised of hydroxyapatite particles and hydroxyapatite fibers. Additionally, 0.154 M NaCI is useful for interactions between titanium and hydroxyapatite.
The next step of the method involves adding between about 20.0 volume percent to about 35.0 volume percent of a relatively fine particulate material b) selected from the group consisting essentially of alumina powder, hydroxyapatite powder or mixtures thereof to the solution a) while stirring the same. Preferably the alumina powder will have an average particle size of between about 50 nanometers (nm) to about 100 micrometers {μm), with a range of 0.2 μm to 0.6 μm being preferred. Alumina powders (AI2O3) such as those marketed by Sumitomo Chemical Co. Ltd. under the trade designation AKP-30 and AKP-50 have been found to be particularly useful.
The hydroxyapatite powders preferably will have an average particle size of between about 0.1 μm to about 100 μm, with a range of 6 μm to about 14 μm being preferred. Hydroxyapatite particles such as those offered commercially by Hitemco iv idical Appliances, Inc. have been found to be particularly useful.
Optionally, a fiber component c) may be added to the solution before sintering. While any suitable biocompatible fiber may be employed, fibers selected from the group consisting essentially of alumina fibers, hydroxyapatite fibers or mixtures thereof are preferred. The total amount of
fibers added will be an amount sufficient to form a relatively pasty slurry. In this regard, it has been found up to about 8.0% by volume of the solid portion of the fibers are suitable, with a range of 4.0% volume to 5.0% by volume being preferred. The alumina fibers, if employed, may be continuous or may be chopped to an average length of less than about 10 mm. More preferably, the short alumina fibers will have an average length of between about 0.5 mm to about 7.0 mm, with a range of between about 1.0 mm to about 3.0 mm being most preferred. The alumina fibers will also preferably have an average diameter of less than 1.0 mm. More preferably, the alumina fibers will have an average diameter of between about 5.0 μm to about 300 μm with a range of between about 10 μm to about 14 μm being most preferred. Such fibers are available from the 3M Corporation under the trade designation NEXTEL AI2O3 fibers.
Likewise, the hydroxyapatite fibers, if employed, may be in the form of the continuous fibers or may be chopped such that they will have an average length of less than 10 mm. More preferably, the short hydroxyapatite fibers will have an average length of between about 0.5 mm to about 7.0 mm, with
a range of between about 1.0 mm to about 3.0 mm being most preferred.
The hydroxyapatite fibers will also have an average diameter of less than 1.0
mm. More preferably, the hydroxyapatite fibers will have an average diameter of between about 5.0 μm to about 300 μm, with a range of 150 μm
to 200 μm being most preferred.
The hydroxyapatite fibers can be made by a simple extrusion method,
by way of non-limiting example. The method includes first, dissolving polyethylene glycol (PEG) in 200 proof ethanol while heating. Hydroxyapatite powder is added at a ratio of 1 part PEG to 3 parts hydroxyapatite powder
(1 :3). The slurry is stirred until enough ethanol has evaporated off to provide the desired viscosity. The mixture is then placed into a 3 cc syringe fitted with a 25 gage needle to extrude the fibers out. The fibers are dried at room temperature in air for 24 hours followed by sintering in air at 1350° C for two hours.
The slurry resulting from the combination of a), b) and optionally c) is
then poured into castings having the desired shape and covered with a porous metal foil. The foil allows evolving gases to escape while acting to maintain a constant slurry volume and controlling the pore size and uniformity of pore distribution. Absent the foil, the slurry tends to foam out and retract, resulting in a non-uniform ceramic product having uncontrolled pore size and an uneven pore distribution. Upon properly covering the castings, the composition is placed in a drying furnace to drive off moisture, thus forming a ceramic shell. The shell
is then allowed to cool to room temperature and is subsequently sintered. As should be understood by those skilled in the ceramics art, the drying times,
cooling times and time and temperatures required for sintering the ceramics is material, shape and volume dependent.
Under an alternative embodiment of the present invention, the resulting
porous ceramic, particularly the non-fiber reinforced porous ceramics, can be
milled such that the granules having a specifically desired size and shape are obtained. Once obtained, the granules can be used for a number of different applications including but not limited to bone fillers, i.e. filling holes left by bone cysts, bone screws, etc. To be used as bone fillers it is preferred that the granules have an average size of between about 1.0 mm to about 2.0 mm.
In addition to bone replacement applications, it should be understood that the porous compositions employing alumina particulate and/or alumina fibers can be employed to form molten metal filters, fuel sessions and catalyst supports by way of non-limiting example. Further, the ceramic compositions employing alumina particulate and alumina fibers may be used for bone
replacement applications since it is considered to be bioinert.
By way of non-limiting example, slurry samples were prepared as shown in Table 1 below and were placed into cylindrical shaped castings having a depth of 2.5 cm and a diameter of 2.5 cm. The samples were dried for 3.0 hours at 120° C in air and thereafter allowed to cool to room
temperature. The samples were then sintered for 1.0 hour at 1600° C for
AI2O3(f)/AI2O3 compositions and for 2.0 hours at 1375° C for AI2O3(f)/HA and HA(f)/HA compositions, wherein (f) is indicative of a fiber component.
After preparing the samples set forth in Table 1 , the samples were sectioned using a diamond edged cutting wheel. The pore diameters were
measured using a stereo microscope and the pore volume for each sample was determined using Archimedes method. Finally, the samples were
examined for chemical purity using energy dispensive spectroscopy (EDS). Table
Figure imgf000015_0001
Table 1 is a listing of "typical" values of reactant components and their corresponding results (i e , micro/macro-porosity, density, etc
While it will be apparent that the preferred embodiments of the invention disclosed are well calculated to fulfill the objects stated, it will be appreciated that as the invention is susceptible to modification, variation and change without departing from the spirit thereof.

Claims

WHAT IS CLAIMED IS:
1. A reinforced porous ceramic comprising: a particulate material selected from the group consisting essentially of alumina powder, hydroxyapatite powder and mixtures thereof; and a fiber component in the form of fibers present in an amount of up to about 8.0 volume % based on the total solids percent.
2. The reinforced porous ceramic of Claim 1 wherein said fiber component is present in an amount of between about 4.0 volume % to about 5.0 volume % based on the total solids percent.
3. The reinforced porous ceramic of Claim 1 wherein said fiber component is selected from the group consisting essentially of alumina fibers, hydroxyapatite fibers and mixtures thereof.
4. The reinforced porous ceramic of Claim 3 wherein said fibers
have an average length of between about 1.0 mm to about 3.0 mm.
5. The reinforced porous ceramic of Claim 3 wherein said hydroxyapatite fibers have an average diameter of between about 150 μm to
about 300 μm.
6. The reinforced porous ceramic of Claim 3 wherein said alumina fibers have an average diameter of between 5 μm to about 300 μm.
7. The reinforced porous ceramic of Claim 1 wherein said
particulate material has an average particle size of up to about 100 μm.
8. The reinforced porous ceramic of Claim 7 wherein said particulate material has an average particle size of about 100 μm.
9. The reinforced porous ceramic of Claim 1 wherein said porous ceramic has an average micropore size of at least 15.0 μm.
10. The reinforced porous ceramic of Claim 9 wherein said porous ceramic has an average macropore size of at least 150 μm.
11. The reinforced porous ceramic of Claim 1 wherein said porous ceramic has an average macropore size of at least 150 μm.
12. The reinforced porous ceramic of Claim 11 wherein said porous
ceramic has an average macropore size between about 200 μm to about 500 μm.
13. A method of forming a porous ceramic component comprising the steps of: a) providing an electrolyte solution; b) admixing into the electrolyte solution a particulate material
selected from the group consisting essentially of alumina powder, hydroxyapatite powder and mixtures thereof to obtain a slurry; c) covering said slurry with a porous metallic foil to allow evolving gas to escape; d) heating said slurry to drive off moisture, thereby forming a porous ceramic shell; e) cooling said ceramic shell until the shell temperature is below about 25° C; and f) sintering the ceramic shell to obtain the porous ceramic component.
14. The method of Claim 13 wherein said electrolyte solution is
selected from the group consisting of NaCI, LiCI, CaCI2, NH4CI, MgCI2, BaCI2, Ca(NO3)2, MgSO4, K2SO4, NaNO3, ZnCI2, K2Cr2O7, Na2PO4, AICI3, KNO3,
AI2(SO4)3, KCI and Ce(NO3)3.
15. The method of Claim 12 wherein said electrolyte solution comprises 10"3M KNO3 including about 30% by volume of concentrated H2O2.
16. The method of Claim 13 comprising the additional step g) of milling the sintered porous ceramic to obtain granules.
17. The method of Claim 16 wherein said granules have an average
size of between about 1.0 mm and 2.0 mm.
18. The method of Claim 16 wherein said granules are useful as bone fillers.
19. The method of Claim 13 comprising an additional step after b) but before c) of adding a fiber component in an amount of up to about 8.0 volume % based on the total solids volume.
20. The method of Claim 19 wherein said fiber component is present in an amount of between about 4.0 volume % to about 5.0 volume % based on the total solids percent.
21. The method of Claim 19 wherein said fiber component is
selected from the group consisting essentially of alumina fibers, hydroxyapatite fibers and mixtures thereof.
22. The method of Claim 19 wherein said fibers have an average
length of at least about 1.0 mm.
23. The method of Claim 19 wherein said hydroxyapatite fibers have an average diameter of between about 150 μm to about 200 μm.
24. The method of Claim 19 wherein said hydroxyapatite particulate material has an average particle size of from about 6 μm to about 14 μm.
25. The method of Claim 19 wherein said alumina particulate material has an average particle size of from about 0.2 μm to about 0.6 μm.
26. The method of Claim 13 wherein said porous ceramic has an
average micropore size of at least 15.0 μm.
27. The method of Claim 26 wherein said porous ceramic has an average micropore size of between about 45.0 μm to about 75.0 μm.
28. The method of Claim 13 wherein said porous ceramic has an
average macropore size of at least 150 μm.
29. The method of Claim 28 wherein said porous ceramic has an average macropore size of between about 200 μm to about 500 μm. AMENDED CLAIMS
[received by the International Bureau on 04 April 2000 (04.04.00); original claims 1-29 replaced by amended claims 1-23 (5 pages)]
WHAT IS CLAIMED IS:
1. A reinforced porous bone substitution ceramic comprising: a hydroxyapatite powder having an average particle size of between about 0.1 μm and 100 μm; and a fiber component in the form of inorganic fibers present in an amount of between about 0.5 volume % to about 8.0 volume % based on the total solids percent; wherein said porous ceramic has a macropore size of at least 150 μm, a micropore size of at least 15 μm and a total porosity of at least 60%.
2. The reinforced porous bone substitution ceramic of Claim 1 wherein said fiber component is present in an amount of between about 4.0 volume % to about 5.0 volume % based on the total solids percent.
3. The reinforced porous bone substitution ceramic of Claim 1 wherein
said fiber component is selected from the group consisting essentially of alumina
fibers, hydroxyapatite fibers and mixtures thereof.
4. The reinforced porous bone substitution ceramic of Claim 3 wherein said fibers have an average length of between about 1.0 mm to about 3.0 mm.
5. The reinforced porous bone substitution ceramic of Claim 3 wherein said hydroxyapatite fibers have an average diameter of between about 150 μm to about 300 μm.
6. The reinforced porous bone substitution ceramic of Claim 3 wherein said alumina fibers have an average diameter of between 5 μm to about 300 μm.
7. The reinforced porous bone substitution ceramic of Claim 1 wherein
said porous ceramic has an average micropore size of between about 45.0 μm to about 75.0 μm.
8. A method of forming a porous ceramic component comprising the steps of: a) providing an electrolyte solution; b) admixing into the electrolyte solution a particulate material selected
from the group consisting of alumina powder, hydroxyapatite powder and mixtures thereof to obtain a slurry;
c) adding a fiber component in the form of inorganic fibers present in an amount of between 0.5 volume % to about 8.0 volume % based on the total solids percent;
d) covering said slurry with a porous metallic foil to allow evolving gas to escape;
e) heating said slurry to drive off moisture, thereby forming a porous ceramic shell;
f) cooling said ceramic shell until the shell temperature is below about 25° C; and
g) sintering the ceramic shell to obtain the porous ceramic component.
9. The method of Claim 8 wherein said electrolyte solution is selected from the group consisting of NaCI, LiCI, CaCI2, NH4CI, MgCI2, BaCI2, Ca(NO3)2, MgSO4, K2SO4, NaNO3, ZnCI2, K2Cr2O7, Na2PO4, AICI3, KNO3, AI2(SO4)3, KCI and Ce(NO3)3.
10. The method of Claim 9 wherein said electrolyte solution comprises 10" 3M KNO3 including about 30% by volume of concentrated H2O2.
11. The method of Claim 8 comprising the additional step h) of milling the sintered porous ceramic to obtain granules.
12. The method of Claim 8 wherein said granules have an average size of between about 1.0 mm and 2.0 mm.
13. The method of Claim 8 wherein said granules are useful as bone fillers.
14. The method of Claim 8 wherein said fiber component is present in an
amount of between about 4.0 volume % to about 5.0 volume % based on the total solids percent.
15. The method of Claim 14 wherein said inorganic fiber component is
selected from the group consisting essentially of alumina fibers, hydroxyapatite
fibers and mixtures thereof.
16. The method of Claim 14 wherein said inorganic fibers have an average
length of at least about 1.0 mm.
17. The method of Claim 14 wherein said hydroxyapatite fibers have an average diameter of between about 150 μm to about 200 μm.
18. The method of Claim 14 wherein said hydroxyapatite particulate material has an average particle size of from about 6 μm to about 14 μm.
19. The method of Claim 14 wherein said alumina particulate material has an average particle size of from about 0.2 μm to about 0.6 μm.
20. The method of Claim 8 wherein said porous ceramic has an average micropore size of at least 15.0 μm.
21. The method of Claim 21 wherein said porous ceramic has an average micropore size of between about 45.0 μm to about 75.0 μm.
22. The method of Claim 8 wherein said porous ceramic has an average macropore size of at least 150 μm.
23. The method of Claim 23 wherein said porous ceramic has an average macropore size of between about 200 μm to about 500 μm.
PCT/US1999/027378 1998-11-20 1999-11-18 Porous ceramic composites WO2000030998A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU19162/00A AU1916200A (en) 1998-11-20 1999-11-18 Porous ceramic composites

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19738798A 1998-11-20 1998-11-20
US09/197,387 1998-11-20

Publications (1)

Publication Number Publication Date
WO2000030998A1 true WO2000030998A1 (en) 2000-06-02

Family

ID=22729204

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/027378 WO2000030998A1 (en) 1998-11-20 1999-11-18 Porous ceramic composites

Country Status (2)

Country Link
AU (1) AU1916200A (en)
WO (1) WO2000030998A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005016192A2 (en) * 2003-08-12 2005-02-24 University Of Bath Bone substitute material
US7910124B2 (en) 2004-02-06 2011-03-22 Georgia Tech Research Corporation Load bearing biocompatible device
US8002830B2 (en) 2004-02-06 2011-08-23 Georgia Tech Research Corporation Surface directed cellular attachment
CN102512706A (en) * 2011-12-16 2012-06-27 天津大学 Calcium polyphosphate/calcium sulfate complex phase biologic ceramic material and preparation method thereof
US8288452B2 (en) * 2003-05-15 2012-10-16 Lo Wei J Synthetic bone graft biomaterial
CN103599561A (en) * 2013-11-07 2014-02-26 同济大学 Preparation method of magnesium alloy/hydroxyapatite composite
CN104310442A (en) * 2014-10-10 2015-01-28 山东诺贝丰化学有限公司 Ammonium chloride forced circulating continuous triple-effect concentration and vacuum crystallization system and ammonium chloride forced circulating continuous triple-effect concentration and vacuum crystallization process in production of potassium nitrate by double decomposition method
CN104310438A (en) * 2014-10-10 2015-01-28 山东诺贝丰化学有限公司 System and method for producing potassium nitrate by adopting continuous double-decomposition method
CN104310439A (en) * 2014-10-10 2015-01-28 山东诺贝丰化学有限公司 Wastewater recycling system and wastewater recycling method in coproduction of potassium nitrate and ammonium chloride
CN104561627A (en) * 2014-12-17 2015-04-29 辽宁工业大学 Preparation method of gradient hydroxyapatite/magnesium composite material
US9155543B2 (en) 2011-05-26 2015-10-13 Cartiva, Inc. Tapered joint implant and related tools
US9907663B2 (en) 2015-03-31 2018-03-06 Cartiva, Inc. Hydrogel implants with porous materials and methods
CN109336560A (en) * 2018-10-04 2019-02-15 南京航空航天大学溧水仿生产业研究院有限公司 Porous shell ceramic matric composite and preparation method thereof
US10350072B2 (en) 2012-05-24 2019-07-16 Cartiva, Inc. Tooling for creating tapered opening in tissue and related methods
US10758374B2 (en) 2015-03-31 2020-09-01 Cartiva, Inc. Carpometacarpal (CMC) implants and methods

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112694320B (en) * 2020-12-28 2023-03-10 山东鲁阳节能材料股份有限公司 Ceramic fiber inorganic board and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929971A (en) * 1973-03-30 1975-12-30 Research Corp Porous biomaterials and method of making same
US4629464A (en) * 1984-09-25 1986-12-16 Tdk Corporation Porous hydroxyapatite material for artificial bone substitute
US4861733A (en) * 1987-02-13 1989-08-29 Interpore International Calcium phosphate bone substitute materials
US5030611A (en) * 1987-10-22 1991-07-09 Asahi Kogaku Kogyo K.K. Porous ceramics material

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929971A (en) * 1973-03-30 1975-12-30 Research Corp Porous biomaterials and method of making same
US4629464A (en) * 1984-09-25 1986-12-16 Tdk Corporation Porous hydroxyapatite material for artificial bone substitute
US4861733A (en) * 1987-02-13 1989-08-29 Interpore International Calcium phosphate bone substitute materials
US5030611A (en) * 1987-10-22 1991-07-09 Asahi Kogaku Kogyo K.K. Porous ceramics material

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8288452B2 (en) * 2003-05-15 2012-10-16 Lo Wei J Synthetic bone graft biomaterial
WO2005016192A3 (en) * 2003-08-12 2005-04-21 Univ Bath Bone substitute material
EP2206525A3 (en) * 2003-08-12 2010-11-17 University Of Bath Bone substitute material
US8101268B2 (en) 2003-08-12 2012-01-24 University Of Bath Bone substitute material
WO2005016192A2 (en) * 2003-08-12 2005-02-24 University Of Bath Bone substitute material
US8895073B2 (en) 2004-02-06 2014-11-25 Georgia Tech Research Corporation Hydrogel implant with superficial pores
US7910124B2 (en) 2004-02-06 2011-03-22 Georgia Tech Research Corporation Load bearing biocompatible device
US8002830B2 (en) 2004-02-06 2011-08-23 Georgia Tech Research Corporation Surface directed cellular attachment
US8486436B2 (en) 2004-02-06 2013-07-16 Georgia Tech Research Corporation Articular joint implant
US11278411B2 (en) 2011-05-26 2022-03-22 Cartiva, Inc. Devices and methods for creating wedge-shaped recesses
US9155543B2 (en) 2011-05-26 2015-10-13 Cartiva, Inc. Tapered joint implant and related tools
US10376368B2 (en) 2011-05-26 2019-08-13 Cartiva, Inc. Devices and methods for creating wedge-shaped recesses
US9526632B2 (en) 2011-05-26 2016-12-27 Cartiva, Inc. Methods of repairing a joint using a wedge-shaped implant
CN102512706A (en) * 2011-12-16 2012-06-27 天津大学 Calcium polyphosphate/calcium sulfate complex phase biologic ceramic material and preparation method thereof
US10350072B2 (en) 2012-05-24 2019-07-16 Cartiva, Inc. Tooling for creating tapered opening in tissue and related methods
CN103599561B (en) * 2013-11-07 2015-08-19 同济大学 A kind of preparation method of magnesium alloy/hydroxyapatite composite
CN103599561A (en) * 2013-11-07 2014-02-26 同济大学 Preparation method of magnesium alloy/hydroxyapatite composite
CN104310442A (en) * 2014-10-10 2015-01-28 山东诺贝丰化学有限公司 Ammonium chloride forced circulating continuous triple-effect concentration and vacuum crystallization system and ammonium chloride forced circulating continuous triple-effect concentration and vacuum crystallization process in production of potassium nitrate by double decomposition method
CN104310439A (en) * 2014-10-10 2015-01-28 山东诺贝丰化学有限公司 Wastewater recycling system and wastewater recycling method in coproduction of potassium nitrate and ammonium chloride
CN104310438A (en) * 2014-10-10 2015-01-28 山东诺贝丰化学有限公司 System and method for producing potassium nitrate by adopting continuous double-decomposition method
CN104561627A (en) * 2014-12-17 2015-04-29 辽宁工业大学 Preparation method of gradient hydroxyapatite/magnesium composite material
CN104561627B (en) * 2014-12-17 2016-08-17 辽宁工业大学 A kind of preparation method of gradient hydroxyapatite/magnesium base composite material
US9907663B2 (en) 2015-03-31 2018-03-06 Cartiva, Inc. Hydrogel implants with porous materials and methods
US10758374B2 (en) 2015-03-31 2020-09-01 Cartiva, Inc. Carpometacarpal (CMC) implants and methods
US10973644B2 (en) 2015-03-31 2021-04-13 Cartiva, Inc. Hydrogel implants with porous materials and methods
US11717411B2 (en) 2015-03-31 2023-08-08 Cartiva, Inc. Hydrogel implants with porous materials and methods
US11839552B2 (en) 2015-03-31 2023-12-12 Cartiva, Inc. Carpometacarpal (CMC) implants and methods
US10952858B2 (en) 2015-04-14 2021-03-23 Cartiva, Inc. Tooling for creating tapered opening in tissue and related methods
US11020231B2 (en) 2015-04-14 2021-06-01 Cartiva, Inc. Tooling for creating tapered opening in tissue and related methods
US11701231B2 (en) 2015-04-14 2023-07-18 Cartiva, Inc. Tooling for creating tapered opening in tissue and related methods
CN109336560A (en) * 2018-10-04 2019-02-15 南京航空航天大学溧水仿生产业研究院有限公司 Porous shell ceramic matric composite and preparation method thereof

Also Published As

Publication number Publication date
AU1916200A (en) 2000-06-13

Similar Documents

Publication Publication Date Title
WO2000030998A1 (en) Porous ceramic composites
Engin et al. Preparation of Porous Ca10 (PO4) 6 (OH) 2 and β‐Ca3 (PO4) 2 Bioceramics
Miao et al. Porous calcium phosphate ceramics modified with PLGA–bioactive glass
JP3362267B2 (en) Bioimplant material and method for producing the same
US8613876B2 (en) Foamed ceramics
Sopyan et al. Synthesis of nano sized hydroxyapatite powder using sol-gel technique and its conversion to dense and porous bodies
Lett et al. Porous hydroxyapatite scaffolds for orthopedic and dental applications-the role of binders
Aguilar-Reyes et al. Processing and in vitro bioactivity of high-strength 45S5 glass-ceramic scaffolds for bone regeneration
EP2212261A2 (en) Method of fabricating porous ceramic structures based on calcium phosphates, alumina or zirconia
KR100565562B1 (en) A continuously porous ceramic body by fibrous monolithic process and manufacturing method thereof
KR20180062132A (en) Composition for three-dimensional ceramic scaffold having dual-pore
CN1200043C (en) Inorganic/organic nano-composite bioactivity porous material and its preparation method
Nakahira et al. Fracture behavior and biocompatibility evaluation of nylon-infiltrated porous hydroxyapatite
Sabudin et al. Effect of mechanical properties on porous calcium phosphate scaffold
JPH0214866A (en) Solution of calcium phosphate compound ceramic precursor and production thereof
Swain Processing of porous hydroxyapatite scaffold
Novak et al. TiO 2 foams with poly-(d, l-lactic acid)(PDLLA) and PDLLA/Bioglass® coatings for bone tissue engineering scaffolds
JPH03131580A (en) Production of porous ceramic sintered material
Guidara et al. Structural and Mechanical Properties of Porous Al2O3-Fap-TiO2 Composite as a Promising Material for Bone Implants
EP1411035B1 (en) A process for the production of porous calcium phosphate articles for bone regeneration and as a support for cells and the porous articles themselves
Bose et al. Processing of bioceramic implants via fused deposition process
RU2771017C1 (en) Method for producing bioactive ceramics based on zirconium dioxide
RU2225227C2 (en) Alumina-based foamed-ceramic material, a product from foamed-ceramic material, and a method for manufacture thereof
Ahmed et al. Porous hydroxyapatite ceramics fabricated via starch consolidation technique
Gremillard et al. Elaboration of self-coating alumina-based porous ceramics

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase